Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Equities
002864
CNE1000032C9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.05 CNY | -0.53% | -0.63% | -21.93% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 3,319 | 4,047 | 3,160 | - |
Enterprise Value (EV) 1 | 3,319 | 4,047 | 3,160 | 3,160 |
P/E ratio | 33.2 x | - | - | - |
Yield | - | 0.57% | 0.67% | 0.67% |
Capitalization / Revenue | - | 4.13 x | 2.16 x | 1.73 x |
EV / Revenue | - | 4.13 x | 2.16 x | 1.73 x |
EV / EBITDA | - | 24.6 x | 14.6 x | 11.7 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | 2.64 x | 2.1 x | 1.85 x |
Nbr of stocks (in thousands) | 85,557 | 105,155 | 105,155 | - |
Reference price 2 | 38.79 | 38.49 | 30.05 | 30.05 |
Announcement Date | 4/21/23 | 4/25/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | 980.8 | 1,465 | 1,824 |
EBITDA 1 | - | 164.9 | 216.1 | 270.2 |
EBIT 1 | - | 134.9 | 196.2 | 251.4 |
Operating Margin | - | 13.75% | 13.39% | 13.78% |
Earnings before Tax (EBT) | - | - | - | - |
Net income | 101.2 | - | - | - |
Net margin | - | - | - | - |
EPS | 1.170 | - | - | - |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share 2 | - | 0.2200 | 0.2000 | 0.2000 |
Announcement Date | 4/21/23 | 4/25/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt | - | - | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | 9.04% | 8.87% | 10.2% |
ROA (Net income/ Total Assets) | - | - | 8.9% | 10.2% |
Assets | - | - | - | - |
Book Value Per Share 1 | - | 14.60 | 14.30 | 16.20 |
Cash Flow per Share 1 | - | 0.9800 | 1.480 | 2.100 |
Capex 2 | - | 62.4 | 10.6 | 14.4 |
Capex / Sales | - | 6.36% | 0.72% | 0.79% |
Announcement Date | 4/21/23 | 4/25/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 438M | |
+32.36% | 694B | |
+30.38% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 002864 Stock
- Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd